EyePoint Pharmaceuticals, Inc. - EYPT

SEC FilingsOur EYPT Tweets

About Gravity Analytica

Recent News

  • 04.16.2025 - EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • 04.16.2025 - EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • 04.04.2025 - RBC Capital Markets Ophthalmology Virtual Conference
  • 04.04.2025 - RBC Capital Markets Ophthalmology Virtual Conference
  • 03.27.2025 - EyePoint to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference
  • 03.27.2025 - EyePoint to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference
  • 03.17.2025 - EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • 03.17.2025 - EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • 03.12.2025 - Barclays 27th Annual Global Healthcare Conference
  • 03.12.2025 - Barclays 27th Annual Global Healthcare Conference

Recent Filings

  • 03.20.2025 - 4 Statement of changes in beneficial ownership of securities
  • 03.06.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]